REIMAGINING CANCER TREATMENT MANAGEMENT

High-affinity tests that monitor the use of onco-therapeutics that support cancer treatment de-escalation to achieve better outcomes with less drug, less cost and improved quality of life.

Martell was organized to launch the next paradigm—how best to manage precision treatments (targeted cancer drugs).  Our mission of de-escalation can be accomplished with inexpensive blood tests (tumor biomarker tests) that quickly document drug efficacy, remission and recurrence. 

OUR TESTS

HERTEST

A Breast Cancer Blood Test

HERTEST rises with tumor progression and falls when treatment is effective.

CHECKMARK

A Serum Test to Measure Soluble PD-L1

CHECKMARK is elevated in patients with several cancer types.